In order to further strengthen Dizlin Pharmaceuticals’ collaboration with researchers at the Sahlgrenska Academy at the University of Gothenburg, the company has agreed to sponsor a PhD position at the Department of Pharmacology.

The research collaboration is focused on Parkinson’s disease with the aim to get new insights in the understanding of the brain disorder. This can be of great value for Dizlin Pharmaceuticals in the company’s ambition to develop innovative and effective products that improve the quality of life for Parkinson patients.